Search for: "BRISTOL-MYERS SQUIBB" Results 321 - 340 of 863
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Apr 2016, 7:35 am by Devika Agarwal
The first application pertained to Bristol-Myers Squibb’s cancer drug, Dastanib, which was filed by Indian generic drug manufacturer, BDR Pharma. [read post]
12 Apr 2016, 10:57 am by Dr. Shezad Malik
Nicholas Meyer recently filed against Bristol-Myers Squibb and Otsuka Pharmaceutical Co. in the U.S. [read post]
8 Apr 2016, 9:14 am by Lawrence B. Ebert
(“Merial”) and Bristol-Myers Squibb(“BMS”) (together, “appellees”). [read post]
8 Mar 2016, 8:01 am by Dr. Shezad Malik
Nicholas Meyer recently filed against Bristol-Myers Squibb and Otsuka Pharmaceutical Co. in the U.S. [read post]
15 Feb 2016, 5:56 am by Law Offices of Jeffrey S. Glassman
According to a recent news feature from Fierce Pharma, Bristol-Myers Squibb (BMY) has reported huge profits over the past fiscal quarter. [read post]
24 Jan 2016, 6:11 am by Michael Bersani
,  lawsuits are swarming around the creators of the drugs (Bristol-Myers Squibb and Otsuka Pharmaceuticals for Abilify, Pfizer and Boehringer Ingelheim for Mirapex). [read post]
20 Jan 2016, 5:21 am by Mary Jane Wilmoth
The SEC Office of the Whistleblower posts Notices of Covered Action where a final judgment or order, by itself or together with other prior judgments or orders in the same action issued after July 21, 2010, results in monetary sanctions exceeding $1 million. [read post]
7 Jan 2016, 1:37 pm by Tom Lamb
From the this December 23, 2015 Reuters news report, "New blood thinner 'antidote' to help doctors move past warfarin", we get some insight about this current "no antidote" situation: Xarelto, from Bayer AG and Johnson & Johnson, and Eliquis, sold by Bristol-Myers Squibb and Pfizer, were approved as safer and more convenient alternatives for preventing blood clots and strokes than warfarin. [read post]
1 Dec 2015, 11:50 am by Brenda Fulmer
  Other drugs in this class include Pradaxa (which was the subject of a confidential settlement in 2014 resolving 4,000 individual lawsuits) and Eliquis (also known as apixaban and marketed by Bristol-Myers Squibb). [read post]
10 Nov 2015, 11:33 am by Tom Lamb
Reporting at the American Heart Association 2015 Scientific Sessions in Orlando, FL, a team of drug company researchers offered results of a retrospective cohort study showing that apixaban (Eliquis/Bristol-Myers-Squibb/Pfizer) had a lower risk of bleeding.... [read post]
10 Nov 2015, 3:41 am by Broc Romanek
Don’t forget to tune in today for the webcast – “How to Draft Meaningful Sustainability Reports” – to hear Lou Coppola of the Governance & Accountability Institute, Kate Kelly of Bristol-Myers Squibb and Pam Styles of Next Level Investor Relations explain the keys to drafting sustainability reports that are meaningful to investors & other constituents and a “how to” list of things you should be aware of when drafting. [read post]
9 Nov 2015, 7:39 am
BackgroundOno owns a patent relating to immunotherapy -- specifically the use of anti-PD-1 antibodies for treating cancer (and Bristol-Myers Squibb is the exclusive licensee). [read post]
9 Nov 2015, 3:55 am by Broc Romanek
Would be used much more than XBRL…” Webcast: “How to Draft Meaningful Sustainability Reports” Tune in tomorrow for the webcast – “How to Draft Meaningful Sustainability Reports” – to hear Lou Coppola of the Governance & Accountability Institute, Kate Kelly of Bristol-Myers Squibb and Pam Styles of Next Level Investor Relations explain the keys to drafting sustainability reports that are meaningful to investors &… [read post]
2 Nov 2015, 7:42 am by Altman & Altman
Its joint manufacturers, Pfizer and Bristol-Myers Squibb, have recently kicked off a targeted direct-to-consumer advertising campaign to market the drug for a-fib treatment as well as for newly approved uses. [read post]
26 Oct 2015, 8:05 am by SEClaw Staff
Two Grant Thornton Firms With Violating Auditor Independence RulesGrant Thornton India LLP and Australia-based Grant Thornton Audit Pty Limited have been charged with auditor independence violations that occurred when two Grant Thornton Mauritius partners served on the boards of Mauritius-based subsidiaries of companies that were Grant Thornton audit clients and performed non-audit services prohibited under the SEC’s auditor independence rules.New Jersey Fund Manager Charged With Securities… [read post]